Evernow, a telemedicine company focused on perimenopause and menopause, raised $28.5 million from a cadre of venture capital firms, technology leaders and celebrity backers.
Why it matters: A lot of money has been poured into fertility in the last few months, but very few companies focus on supporting women’s health once they get through this (entirely optional!) phase.
Details: Individual investors include Gwynne Shotwell, COO of SpaceX, Othman Laraki, CEO of Color, Drew Barrymore, Gwyneth Paltrow, Carla Harris and Cameron Diaz.
How it works: Prospective users fill out a questionnaire to rule out medical issues that could interfere with treatment, and San Francisco-based Evernow then matches them with a clinician to whom they can ask questions via text and email if symptoms change.
Yes but: Evernow doesn’t accept insurance, and its plans cost $75 to $129 per month.
- Evernow fills a cash-plus-telemedicine niche that’s similar to Hims & Hers or Ro but specific to menopause, says women’s health investor Leslie Schrock.
For more information, see Axios Pro Health Tech Deals.
Comments are closed.